Identification of Purity and Prognosis-related Gene Signature by Network Analysis and Survival Analysis in Brain Lower Grade Glioma

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2020 Sep 2

PMID 32869484

Citations 16

Authors

Zujian Xiong

Yi Xiong

Hongwei Liu

Chang Li

Xuejun Li

Affiliations

Soon will be listed here.

Abstract

Tumour microenvironment of brain lower grade glioma (LGG) consists of non-tumour cells including stromal cells and immune cells mainly. These non-tumour cells dilute the purity of LGG and play pivotal roles in tumour growth and development, thereby affecting patient prognosis. Tumour purity is also associated with molecular subtypes of LGG. In this study, we discovered the most relevant module to purity by weighted gene co-expression network analysis (WGCNA) and afterwards performed consensus network analysis and survival analysis to filter 61 significant genes related to both purity and prognosis. In turn, we built a simplified model based on the calculation of purity score, and consensus measurement of purity estimation (CPE), with a satisfactory predictive performance by random forest regression. HLA-E, MSN, GNG-5, MYL12A, ITGB4, PDPN, AGTRAP, S100A4, PLSCR1, VAMP5 were selected as the most relevant genes correlating to both purity and prognosis. The risk score model based on the 10 genes could moderately predict patients' overall survival. These 10 genes, respectively, were positively correlated positively to immunosuppressive cells like macrophage M2, but negatively correlated to patient prognosis, which may explain partially the poor prognosis with low-purity group.

Citing Articles

Identification of tumor-specific T cell signature predicting cancer immunotherapy response in bladder cancer by multi-omics analysis and experimental verification.

Liu X, Chen C, Li J, Li L, Ma M Cancer Cell Int. 2024; 24(1):255.

PMID: 39033098 PMC: 11264995. DOI: 10.1186/s12935-024-03447-6.

ITGB4 upregulation is associated with progression of lower grade glioma.

Chen P, Ma T, Yan T, Song Z, Liu C, Pan C Sci Rep. 2024; 14(1):421.

PMID: 38172503 PMC: 10764336. DOI: 10.1038/s41598-023-49801-y.

Construction and validation of a risk model based on the key SNARE proteins to predict the prognosis and immune microenvironment of gliomas.

Yin L, Xu Y, Yin J, Cheng H, Xiao W, Wu Y Front Mol Neurosci. 2023; 16:1304224.

PMID: 38115820 PMC: 10728289. DOI: 10.3389/fnmol.2023.1304224.

miR-21-5p inhibits the growth of brain glioma cells through regulating the glycolysis mediated by PFKFB2.

Zhang L, Liu J Funct Integr Genomics. 2023; 23(4):322.

PMID: 37864733 PMC: 10590297. DOI: 10.1007/s10142-023-01246-2.

Overexpression of RAB34 associates with tumor aggressiveness and immune infiltration in glioma.

Hou P, Wan Q, Wang Q, Wu X, Lu X Biosci Rep. 2022; 42(10).

PMID: 36222286 PMC: 9620491. DOI: 10.1042/BSR20212624.

References

Mildenberger I, Bunse L, Ochs K, Platten M . The promises of immunotherapy in gliomas. Curr Opin Neurol. 2017; 30(6):650-658. DOI: 10.1097/WCO.0000000000000491. View

Ma Q, Long W, Xing C, Chu J, Luo M, Wang H . Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma. Front Immunol. 2019; 9:2924. PMC: 6308128. DOI: 10.3389/fimmu.2018.02924. View

Aran D, Sirota M, Butte A . Systematic pan-cancer analysis of tumour purity. Nat Commun. 2015; 6:8971. PMC: 4671203. DOI: 10.1038/ncomms9971. View

Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View

Golebiewska A, Bougnaud S, Stieber D, Brons N, Vallar L, Hertel F . Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain. 2013; 136(Pt 5):1462-75. PMC: 3634193. DOI: 10.1093/brain/awt025. View

Binder H, Willscher E, Loeffler-Wirth H, Hopp L, Jones D, Pfister S . DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development. Acta Neuropathol Commun. 2019; 7(1):59. PMC: 6482573. DOI: 10.1186/s40478-019-0704-8. View

Cohen D, Dabbs D, Cooper K, Amin M, Jones T, Jones M . Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma. Am J Clin Pathol. 2012; 138(6):796-802. DOI: 10.1309/AJCP6DKRND5CKVDD. View

Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View

Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008; 9:559. PMC: 2631488. DOI: 10.1186/1471-2105-9-559. View

10.

Noy R, Pollard J . Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014; 41(1):49-61. PMC: 4137410. DOI: 10.1016/j.immuni.2014.06.010. View

11.

Zhang C, Cheng W, Ren X, Wang Z, Liu X, Li G . Tumor Purity as an Underlying Key Factor in Glioma. Clin Cancer Res. 2017; 23(20):6279-6291. DOI: 10.1158/1078-0432.CCR-16-2598. View

12.

Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

13.

Xiong Z, Xiong Y, Liu H, Li C, Li X . Identification of purity and prognosis-related gene signature by network analysis and survival analysis in brain lower grade glioma. J Cell Mol Med. 2020; 24(19):11607-11612. PMC: 7576230. DOI: 10.1111/jcmm.15805. View

14.

Yu G, Wang L, Han Y, He Q . clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012; 16(5):284-7. PMC: 3339379. DOI: 10.1089/omi.2011.0118. View

15.

Mirzaei R, Sarkar S, Yong V . T Cell Exhaustion in Glioblastoma: Intricacies of Immune Checkpoints. Trends Immunol. 2016; 38(2):104-115. DOI: 10.1016/j.it.2016.11.005. View

16.

Zhao Z, Meng F, Wang W, Wang Z, Zhang C, Jiang T . Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas. Sci Data. 2017; 4:170024. PMC: 5349247. DOI: 10.1038/sdata.2017.24. View